Type / Class
Equity / Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares
Shares outstanding
791M
Number of holders
59
Total 13F shares, excl. options
78.5M
Shares change
+5.3M
Total reported value, excl. options
$181M
Value change
+$12.8M
Put/Call ratio
0.12
Number of buys
32
Number of sells
-19
Price
$2.31

Significant Holders of Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) as of Q4 2023

72 filings reported holding MREO - Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares as of Q4 2023.
Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 78.5M shares of 791M outstanding shares and own 9.92% of the company stock.
Largest 10 shareholders include Rubric Capital Management LP (13.6M shares), Soleus Capital Management, L.P. (9.78M shares), MANGROVE PARTNERS (8.75M shares), Rock Springs Capital Management LP (7.98M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (7.37M shares), 683 Capital Management, LLC (6.2M shares), ALKEON CAPITAL MANAGEMENT LLC (4.24M shares), Tejara Capital Ltd (3.71M shares), Clearline Capital LP (3.33M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (2.65M shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.